The World Health Organization (WHO) said that it still recommends using the AstraZeneca Covid-19 vaccine as the benefits outweigh its risks.
"Vaccination against Covid-19 will not reduce illness or deaths from other causes. Thromboembolic events are known to occur frequently. Venous thromboembolism is the third most common cardiovascular disease globally," the WHO said in a statement on Wednesday.
The statement came after a growing number of countries in the European Union suspended the use of the AstraZeneca vaccine as a precautionary measure, based on reports of blood clots in persons who had received the vaccine, reports Xinhua news agency.
"It is routine for countries to signal potential adverse events following immunization. This does not necessarily mean that the events are linked to vaccination itself, but it is good practice to investigate them.
"It also shows that the surveillance system works and that effective controls are in place," the statement added.
Currently, the WHO Global Advisory Committee on Vaccine Safety is still assessing the latest available safety data for the AstraZeneca vaccine, while keeping in touch with the European Medicines Agency and other regulators around the world for latest safety information.
The WHO said it will immediately communicate the findings to the public once that review is completed.
(This story has been published from a wire agency feed without modifications to the text. Only the headline has been changed.)
As you are no doubt aware, Swarajya is a media product that is directly dependent on support from its readers in the form of subscriptions. We do not have the muscle and backing of a large media conglomerate nor are we playing for the large advertisement sweep-stake.
Our business model is you and your subscription. And in challenging times like these, we need your support now more than ever.
We deliver over 10 - 15 high quality articles with expert insights and views. From 7AM in the morning to 10PM late night we operate to ensure you, the reader, get to see what is just right.
Becoming a Patron or a subscriber for as little as Rs 1200/year is the best way you can support our efforts.